Literature DB >> 17556185

Metabolic adaptation to myocardial ischemia: the role of fatty acid imaging.

Vasken Dilsizian1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17556185     DOI: 10.1016/j.nuclcard.2007.02.008

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  13 in total

Review 1.  Metabolic aspects of programmed cell survival and cell death in the heart.

Authors:  C Depre; H Taegtmeyer
Journal:  Cardiovasc Res       Date:  2000-02       Impact factor: 10.787

2.  Clinical trials report. Metabolic modulation as a principle for myocardial protection.

Authors:  Heinrich Taegtmeyer; Alexis Woods
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

3.  USE OF RADIOIODINATED FATTY ACID FOR PHOTOSCANS OF THE HEART.

Authors:  J R EVANS; R W GUNTON; R G BAKER; D S BEANLANDS; J C SPEARS
Journal:  Circ Res       Date:  1965-01       Impact factor: 17.367

Review 4.  Structural aspects of the chronic hibernating myocardium in man.

Authors:  M Borgers; J Ausma
Journal:  Basic Res Cardiol       Date:  1995 Jan-Feb       Impact factor: 17.165

Review 5.  Current diagnostic techniques of assessing myocardial viability in patients with hibernating and stunned myocardium.

Authors:  V Dilsizian; R O Bonow
Journal:  Circulation       Date:  1993-01       Impact factor: 29.690

6.  Regional assessment of myocardial metabolic integrity in vivo by positron-emission tomography with 11C-labeled palmitate.

Authors:  M M Ter-Pogossian; M S Klein; J Markham; R Roberts; B E Sobel
Journal:  Circulation       Date:  1980-02       Impact factor: 29.690

7.  Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain.

Authors:  Y Kawai; E Tsukamoto; Y Nozaki; K Morita; M Sakurai; N Tamaki
Journal:  J Am Coll Cardiol       Date:  2001-12       Impact factor: 24.094

8.  Myocardial kinetics of iodine-123-BMIPP in canine myocardium after regional ischemia and reperfusion: implications for clinical SPECT.

Authors:  R Hosokawa; R Nohara; Y Fujibayashi; K Okuda; M Ogino; T Hata; M Fujita; N Tamaki; J Konishi; S Sasayama
Journal:  J Nucl Med       Date:  1997-12       Impact factor: 10.057

9.  Reversibility of cardiac wall-motion abnormalities predicted by positron tomography.

Authors:  J Tillisch; R Brunken; R Marshall; M Schwaiger; M Mandelkern; M Phelps; H Schelbert
Journal:  N Engl J Med       Date:  1986-04-03       Impact factor: 91.245

10.  Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging.

Authors:  V Dilsizian; T P Rocco; N M Freedman; M B Leon; R O Bonow
Journal:  N Engl J Med       Date:  1990-07-19       Impact factor: 91.245

View more
  5 in total

Review 1.  Cardiac molecular imaging to track left ventricular remodeling in heart failure.

Authors:  Jamshid Shirani; Amitoj Singh; Sahil Agrawal; Vasken Dilsizian
Journal:  J Nucl Cardiol       Date:  2016-08-01       Impact factor: 5.952

Review 2.  Ischaemic memory imaging using metabolic radiopharmaceuticals: overview of clinical settings and ongoing investigations.

Authors:  Keiichiro Yoshinaga; Masanao Naya; Tohru Shiga; Eriko Suzuki; Nagara Tamaki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-12       Impact factor: 9.236

Review 3.  The role of myocardial viability in contemporary cardiac practice.

Authors:  Abdelrahman Jamiel; Mohamad Ebid; Amjad M Ahmed; Dalia Ahmed; Mouaz H Al-Mallah
Journal:  Heart Fail Rev       Date:  2017-07       Impact factor: 4.214

Review 4.  Radionuclide Imaging Applications in Cardiomyopathies and Heart Failure.

Authors:  Matthew E Harinstein; Prem Soman
Journal:  Curr Cardiol Rep       Date:  2016-03       Impact factor: 2.931

5.  A new F-18 labeled PET tracer for fatty acid imaging.

Authors:  Fabian Demeure; Manuel D Cerqueira; Michel Hesse; David Vancraeynest; Véronique Roelants
Journal:  J Nucl Cardiol       Date:  2014-10-25       Impact factor: 5.952

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.